Sfoglia per AUTORE
JERKEMAN M
Collezione AOU Alessandria

  

Items : 4

2024
AOU Alessandria

Dreyling M; Doorduijn J; Giné E; Jerkeman M; Walewski J; Hutchings M; Mey U; Riise J; Trneny M; Vergote V; Shpilberg O; Gomes da Silva M; Leppä S; Jiang L; Stilgenbauer S; Kerkhoff A; Jachimowicz RD; Celli M; Hess G; Arcaini L; Visco C; van Meerten T; Wirths S; Zinzani PL; Novak U; Herhaus P; Benedetti F; Sonnevi K; Hanoun C; et alii...

Clinical outcome of Mantle Cell Lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression). in Leukemia / Leukemia. 2023 Sep;37(9):1887-1894. doi: 10.1038/s41375-023-01977-y. Epub 2023 Jul 26.
2023
AOU Alessandria
AOU Città della Salute di Torino

Hoster E; Jerkeman M; Ferrero S; Ladetto M; Klapper W; Evangelista A; Unterhalt M; Rosenwald A; Kluin-Nelemans HC; Schmidt C; Jiang L; Hermine O; Dreyling M; Scheubeck G;

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26.
2021
AOU Alessandria

Seymour JF; Herfarth K; Tonino SH; Ladetto M; Salles G; Ghielmini M; Rule S; Dreyling M; Jerkeman M;

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.
2020
AOU Alessandria
AOU Città della Salute di Torino

Bertoni F; Ladetto M; Cortelazzo S; Piccin A; Grønbæk K; Ferreri A; Santoro A; Molinari A; da Silva MG; Zamò A; Jerkeman M; Paulli M; Novero D; Kolstad A; Barbero D; Schipani M; Mahmoud AM; Ghione P; Favini C; Stefoni V; Diop F; Dahl C; Di Rocco A; Kwee I; Moia R; Evangelista A; Spina V; Eskelund CW; Bruscaggin A; et alii...